Filter News
Area of Research
- (-) Neutron Science (12)
- (-) Supercomputing (14)
- Biology and Environment (10)
- Clean Energy (13)
- Fusion and Fission (5)
- Fusion Energy (5)
- Isotopes (4)
- Materials (18)
- Materials for Computing (2)
- National Security (5)
- Nuclear Science and Technology (17)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (2)
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (11)
- (-) Cybersecurity (1)
- (-) Fusion (1)
- (-) Isotopes (1)
- (-) Microscopy (2)
- (-) Nanotechnology (8)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (4)
- Artificial Intelligence (5)
- Big Data (8)
- Bioenergy (4)
- Biology (1)
- Chemical Sciences (1)
- Climate Change (1)
- Computer Science (29)
- Coronavirus (10)
- Decarbonization (1)
- Energy Storage (1)
- Environment (5)
- Exascale Computing (2)
- Frontier (1)
- Grid (2)
- High-Performance Computing (2)
- Machine Learning (4)
- Materials (2)
- Materials Science (12)
- Mathematics (1)
- Molten Salt (1)
- National Security (1)
- Neutron Science (27)
- Nuclear Energy (2)
- Physics (4)
- Polymers (2)
- Quantum Science (10)
- Summit (13)
- Sustainable Energy (4)
- Transportation (2)
Media Contacts
![Distinguished Inventors](/sites/default/files/styles/list_page_thumbnail/public/2020-12/inventors.jpg?h=4631f1c1&itok=xhAGY0kv)
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
![Paul Kent, shown above posing with Summit in April 2018, received the 2020 ORNL Director’s Award for Outstanding Individual Accomplishment in Science and Technology. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/DA_Kent.jpg?h=48cf6540&itok=Ocw9WcgV)
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
![Frontier supercomputer](/sites/default/files/styles/list_page_thumbnail/public/2023-01/frontier_0.jpg?h=a1e1a043&itok=J3IM_Xeh)
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
![ORNL assisted in investigating proteins called porins, one shown in red, which are found in the protective outer membrane of certain disease-causing bacteria and tether the membrane to the cell wall. Credit: Hyea (Sunny) Hwang/Georgia Tech and ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/Biology-gram-negative_0.jpg?h=ced0ee1c&itok=mTOudglI)
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.
![The first neutron structure of the SARS-CoV-2 main protease enzyme revealed unexpected electrical charges in the amino acids cysteine (negative) and histidine (positive), providing key data about the virus’s replication. Credit: Jill Hemman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-10/20-G01620_Protease_PR_proof2_0.jpg?h=3e3883a3&itok=XB_ZEDFQ)
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
![Sarah Cousineau](/sites/default/files/styles/list_page_thumbnail/public/2020-10/2019-P00901%20%281%29.jpg?h=c6980913&itok=TetsY0iB)
Two scientists with the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Physical Society.
![Substituting deuterium for hydrogen makes methylammonium heavier and slows its swaying so it can interact with vibrations that remove heat, keeping charge carriers hot longer. Credit: Jill Hemman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-10/20-G00933_PR_Manley_0.jpg?h=eca34813&itok=3DjqguYT)
Led by ORNL and the University of Tennessee, Knoxville, a study of a solar-energy material with a bright future revealed a way to slow phonons, the waves that transport heat.
![ORNL researchers developed a quantum, or squeezed, light approach for atomic force microscopy that enables measurement of signals otherwise buried by noise. Credit: Raphael Pooser/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-09/cantilever_cell_lower_perspective_composite3a%20copy.jpg?h=cdc5ebd8&itok=MDv06yLW)
Researchers at ORNL used quantum optics to advance state-of-the-art microscopy and illuminate a path to detecting material properties with greater sensitivity than is possible with traditional tools.
![Enzyme activity during organophosphate poisoning](/sites/default/files/styles/list_page_thumbnail/public/2020-08/anecdote1_0.png?h=d1cb525d&itok=wpYYilBI)
Pick your poison. It can be deadly for good reasons such as protecting crops from harmful insects or fighting parasite infection as medicine — or for evil as a weapon for bioterrorism. Or, in extremely diluted amounts, it can be used to enhance beauty.
![Analyses of lung fluid cells from COVID-19 patients conducted on the nation’s fastest supercomputer point to gene expression patterns that may explain the runaway symptoms produced by the body’s response to SARS-CoV-2. Credit: Jason B. Smith/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-07/cells%20200%5B1%5D.png?h=b95f6d72&itok=V2OxqL5l)
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.